Results 1 - 10 of 226
[PROJECT] TRYLEIDIAG - Simplified rapid molecular diagnosis and characterisation of Leishmaniasis and Human African Trypanosomiasis
ID: 15379
Start date: 2005-11-01, End date: 2009-10-31
Human African Trypanosomiasis (HAT), caused by Trypanosoma brucei (T.b.) gambiense or T.b. rhodesiense, affects currently 500.000 people in sub-Saharan Africa. Visceral, cutaneous and mucocutaneous leishmaniases (LEI) are caused by several Leishmania spec ies. Leishmaniases th...
Programme: FP6-INCO
Record Number: 78787
Last updated on: 2010-10-08
[PROJECT] NIDIAG - Syndromic approach to Neglected Infectious Diseases (NID) at primary health care level: an international collaboration on integrated diagnostic-treatment platforms
ID: 260260
Start date: 2010-11-01, End date: 2016-04-30
Neglected Infectious Diseases (NID) such as trypanosomiasis, leishmaniasis, schistosomiasis and soil-transmitted helminthiasis receive less than 5% of the global investment for tropical diseases research. Clinical praxis in disease-endemic countries (DEC) is rarely evidence b...
Programme: FP7-HEALTH
Record Number: 97322
Last updated on: 2017-05-29
[PROJECT] EUROCANPLATFORM - A European Platform for Translational Cancer Research
ID: 260791
Start date: 2011-01-01, End date: 2016-12-31
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer r...
Programme: FP7-HEALTH
Record Number: 97701
Last updated on: 2017-05-29
[PROJECT] RATHER - Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes
ID: 258967
Start date: 2011-01-01, End date: 2018-06-30
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signaling components. While there are several ongoing large-scale genome re-sequen...
Programme: FP7-HEALTH
Record Number: 97660
Last updated on: 2017-07-16
[PROJECT] ASFRISK - Evaluating and controlling the risk of African swine fever in the EU
ID: 211691
Start date: 2008-04-01, End date: 2011-09-30
African swine fever (ASF) in EU member states is currently confined to Italy (Sardinia), it was recently introduced to Caucasian regions and it is highly prevalent in sub-Saharan African countries. In both the EC and Africa changes in the epidemiology of the disease have rece...
Programme: FP7-KBBE
Record Number: 88394
Last updated on: 2017-05-29
[PROJECT] IDEAL - Integrated research on DEvelopmental determinants of Aging and Longevity
ID: 259679
Start date: 2011-02-01, End date: 2016-01-31
IDEAL will obtain insight into the role of early life conditions affecting late-life health, disease and aging, and the role of epigenetic regulation therein. IDEAL will identify the determinants and targets of this epigenetic regulation utilizing a resource of unique human c...
Programme: FP7-HEALTH
Record Number: 98424
Last updated on: 2017-07-12
[PROJECT] EUTRAF - The European Network for Translational Research in Atrial Fibrillation
ID: 261057
Start date: 2010-11-01, End date: 2015-10-31
The initiation and perpetuation of atrial fibrillation (AF) can be regarded as a complication of a progressive transformation of the structure and functional properties of the atria. This transformation is the result of complex and multiple changes at the molecular, cellular ...
Programme: FP7-HEALTH
Record Number: 96749
Last updated on: 2017-07-12
[PROJECT] METOXIA - Metastatic tumours facilitated by hypoxic tumour micro-environments
ID: 222741
Start date: 2009-02-01, End date: 2014-07-31
Recent research suggests that the hypoxic micro-environment of tumours is one of the major drivers of metastatic spread of cancer. Furthermore, hypoxic tumour micro-environments may result in treatment resistance of cancer cells, therefore causing a double effect of reducing ...
Programme: FP7-HEALTH
Record Number: 91061
Last updated on: 2017-07-12
[PROJECT] ANTIFLU - Innovative anti-influenza drugs excluding viral escape
ID: 259842
Start date: 2011-06-01, End date: 2016-11-30
ANTIFLU is to develop innovative drugs against influenza virus infections based on a novel concept that precludes the development of viral resistance and ensures efficacy against upcoming pandemic influenza strains. Viral replication is known to depend on multiple host factor...
Programme: FP7-HEALTH
Record Number: 99759
Last updated on: 2017-05-26
[PROJECT] PANCARESURFUP - PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies
ID: 257505
Start date: 2011-02-01, End date: 2017-01-31
Over the last 40 years, treatment for childhood and adolescent cancer has improved greatly; 5- year survival after childhood cancer is now 80% in developed countries. Approximately 1 individual in 750 of young adults is now a childhood cancer survivor. Epidemiologic data on t...
Programme: FP7-HEALTH
Record Number: 97692
Last updated on: 2017-05-29
List retrieved on: 2017-08-02
